Iron status in obesity: An independent association with metabolic parameters and effect of weight loss

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 25, Issue 6, 2015, Pages 541-547

  Guglielmi, V ^a,b   D'Adamo, M ^a,b   Bellia, A ^a   Ciotto, R T ^a,b   Federici, M ^a   Lauro, D ^a   Sbraccia, P ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Ferritin; Iron status; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID;

ADULT; ARTICLE; BODY FAT; BODY MASS; FEMALE; HUMAN; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; METABOLISM; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WEIGHT REDUCTION; AGED; BLOOD; CALORIC RESTRICTION; DIET THERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADIPOSITY; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOMARKERS; BODY MASS INDEX; CALORIC RESTRICTION; FEMALE; FERRITINS; HUMANS; IRON; LIPIDS; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84930182693     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.02.012     Document Type: Article

References (36)

1. Hentze M.W., Muckenthaler M.U., Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004, 117:285-297.
2. Fernandez-Real J.M., Manco M. Effects of iron overload on chronic metabolic diseases. Lancet Diabetes Endocrinol 2014, 2:513-526.
3. Zacharski L.R., Ornstein D.L., Woloshin S., Schwartz L.M. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000, 140:98-104.
4. Manousou P., Kalambokis G., Grillo F., Watkins J., Xirouchakis E., Pleguezuelo M., et al. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver Int 2011, 31:730-739.
5. Machado M., Cortez-Pinto H. Nash, insulin resistance and iron. Liver Int 2006, 26:1159-1162.
6. Iwasaki T., Nakajima A., Yoneda M., Yamada Y., Mukasa K., Fujita K., et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 2005, 28:2486-2491.
7. Fernandez-Real J.M., Lopez-Bermejo A., Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem. 2005, 51:1201-1205.
8. Jiang R., Manson J.E., Meigs J.B., Ma J., Rifai N., Hu F.B. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. J Am Med Assoc 2004, 291:711-717.
9. Lecube A., Hernandez C., Pelegri D., Simo R. Factors accounting for high ferritin levels in obesity. Int J Obes (Lond) 2008, 32:1665-1669.
10. Kilani N., Waeber G., Vollenweider P., Marques-Vidal P. Markers of iron metabolism and metabolic syndrome in Swiss adults. Nutr Metab Cardiovasc Dis 2014, 24:e28-e29.
11. Dongiovanni P., Ruscica M., Rametta R., Recalcati S., Steffani L., Gatti S., et al. Dietary iron overload induces visceral adipose tissue insulin resistance. Am J Pathol 2013, 182:2254-2263.
12. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
13. Amato A., Santoro N., Calabro P., Grandone A., Swinkels D.W., Perrone L., et al. Effect of body mass index reduction on serum hepcidin levels and iron status in obese children. Int J Obes (Lond) 2010, 34:1772-1774.
14. Schweiger C., Weiss R., Berry E., Keidar A. Nutritional deficiencies in bariatric surgery candidates. Obes Surg 2010, 20:193-197.
15. Micozzi M.S., Albanes D., Stevens R.G. Relation of body size and composition to clinical biochemical and hematologic indices in US men and women. Am J Clin Nutr 1989, 50:1276-1281.
16. Cheng H.L., Bryant C., Cook R., O'Connor H., Rooney K., Steinbeck K. The relationship between obesity and hypoferraemia in adults: a systematic review. Obes Rev. 2012, 13:150-161.
17. Yanoff L.B., Menzie C.M., Denkinger B., Sebring N.G., McHugh T., Remaley A.T., et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 2007, 31:1412-1419.
18. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006, 26:323-342.
19. Ferrannini E. Insulin resistance, iron, and the liver. Lancet 2000, 355:2181-2182.
20. Wlazlo N., van Greevenbroek M.M., Ferreira I., Jansen E.H., Feskens E.J., van der Kallen C.J., et al. Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study. Diabetes Care 2013, 36:309-315.
21. Festa M., Ricciardelli G., Mele G., Pietropaolo C., Ruffo A., Colonna A. Overexpression of H ferritin and up-regulation of iron regulatory protein genes during differentiation of 3T3-L1 pre-adipocytes. J Biol Chem. 2000, 275:36708-36712.
22. Moreno-Navarrete J.M., Manco M., Ibanez J., Garcia-Fuentes E., Ortega F., Gorostiaga E., et al. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int J Obes (Lond) 2010, 34:240-249.
23. Rodriguez-Rodriguez E., Lopez-Sobaler A.M., Andres P., Aparicio A., Navia B., Ortega R.M. Modification of iron status in young overweight/mildly obese women by two dietary interventions designed to achieve weight loss. Ann Nutr Metab 2007, 51:367-373.
24. Beard J., Borel M., Peterson F.J. Changes in iron status during weight loss with very-low-energy diets. Am J Clin Nutr 1997, 66:104-110.
25. Gastaldelli A., Perego L., Paganelli M., Sesti G., Hribal M., Chavez A.O., et al. Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric banding. Obes Surg 2009, 19:80-86.
26. Ramalho R., Guimaraes C., Gil C., Neves C., Guimaraes J.T., Delgado L. Morbid obesity and inflammation: a prospective study after adjustable gastric banding surgery. Obes Surg 2009, 19:915-920.
27. Tao H., Shi K.H., Wu J.X., Zhan H.Y. Nonalcoholic fatty liver disease is a potential risk factor for cardiovascular diseases. Nutr Metab Cardiovasc Dis 2014, 24:e11-e12.
28. Ahmed U., Latham P.S., Oates P.S. Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis. World J Gastroenterol 2012, 18:4651-4658.
29. Whaley-Connell A., McCullough P.A., Sowers J.R. The role of oxidative stress in the metabolic syndrome. Rev Cardiovasc Med 2011, 12:21-29.
30. Rumberger J.M., Peters T., Burrington C., Green A. Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes. Diabetes 2004, 53:2535-2541.
31. Gabrielsen J.S., Gao Y., Simcox J.A., Huang J., Thorup D., Jones D., et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 2012, 122:3529-3540.
32. Simcox J.A., McClain D.A. Iron and diabetes risk. Cell Metab 2013, 17:329-341.
33. Kong W.N., Niu Q.M., Ge L., Zhang N., Yan S.F., Chen W.B., et al. Sex differences in iron status and hepcidin expression in rats. Biol Trace Elem Res 2014, 160:258-267.
34. Tussing-Humphreys L.M., Liang H., Nemeth E., Freels S., Braunschweig C.A. Excess adiposity, inflammation, and iron-deficiency in female adolescents. J Am Diet Assoc. 2009, 109:297-302.
35. Menzie C.M., Yanoff L.B., Denkinger B.I., McHugh T., Sebring N.G., Calis K.A., et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc. 2008, 108:145-148.
36. Sesti G., Fiorentino T.V., Hribal M.L., Sciacqua A., Perticone F. Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers. Nutr Metab Cardiovasc Dis 2013, 23:1182-1187.